Monsanto Co (MON.N)
107.79USD
11:55am EDT
$-0.52 (-0.48%)
$108.31
$108.41
$108.41
$107.40
115,819
586,477
$109.33
$69.87
About
Overall
| Beta: | 0.92 |
| Market Cap (Mil.): | $57,820.30 |
| Shares Outstanding (Mil.): | 533.84 |
| Dividend: | 0.38 |
| Yield (%): | 1.38 |
Financials
| MON.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 23.24 | 17.49 | 21.76 |
| EPS (TTM): | 4.66 | -- | -- |
| ROI: | 15.82 | 7.19 | 16.41 |
| ROE: | 19.97 | 10.46 | 18.71 |
Monsanto tests planting platform, eyes new microbial business
ST. LOUIS - Monsanto Co, the world's largest seed company, is developing two new platforms that diverge from its core business and are seen as potential key long-term growth drivers, according to top Monsanto executives.
UPDATE 1-Monsanto tests planting platform, eyes new microbial business
ST. LOUIS, May 15 - Monsanto Co, the world's largest seed company, is developing two new platforms that diverge from its core business and are seen as potential key long-term growth drivers, according to top Monsanto executives.
Monsanto pressing ahead with GMO crop amid USDA scrutiny
St. Louis, Mo. May 14 - Monsanto Co. is pushing on with plans to introduce a controversial new type of herbicide-tolerant crop, and last week's decision by the U.S. government to extend its scrutiny of the proposed new crops should not spell a significant delay, a top company official said Tuesday.
UPDATE 1-U.S. State Dept. promotes Monsanto's GMO crops overseas -report
* Report critical of State Dept for promoting biotech crops
U.S. tax dollars promote Monsanto's GMO crops overseas: report
- U.S. taxpayers are footing the bill for overseas lobbying that promotes controversial biotech crops developed by U.S.-based Monsanto Co and other seed makers, a report issued on Tuesday said.
U.S. Supreme Court rules for Monsanto in patent fight
WASHINGTON - In a ruling that drew sighs of relief from the biotechnology industry, the U.S. Supreme Court ruled on Monday that an Indiana farmer violated agribusiness company Monsanto Co.'s patent for a type of soybean.
UPDATE 2-U.S. Supreme Court rules for Monsanto in patent fight
WASHINGTON, May 13 - In a ruling that drew sighs of relief from the biotechnology industry, the U.S. Supreme Court ruled on Monday that an Indiana farmer violated agribusiness company Monsanto Co.'s patent for a type of soybean.
U.S. justices rule for Monsanto in patent fight
WASHINGTON, May 13 - The U.S. Supreme Court ruled on Monday that an Indiana farmer violated giant agribusiness company Monsanto Co's patent for a type of soybean.
USDA says more review needed for new Monsanto, Dow GMO crops
- The Department of Agriculture said Friday it will extend its scrutiny of controversial proposed biotech crops developed by Dow AgroSciences, a unit of Dow Chemical, and Monsanto Co. after receiving an onslaught of opposition to the companies' plans.
UPDATE 3-USDA says more review needed for new Monsanto, Dow GMO crops
* Dow's Enlist corn delayed likely until 2015 * Monsanto, Dow say cooperating with USDA * Critics applaud USDA move By Carey Gillam May 10 - The U.S. Department of Agriculture said Friday it will extend its scrutiny of controversial proposed biotech crops developed by Dow AgroSciences, a unit of Dow Chemical, and Monsanto Co. after receiving an onslaught of opposition to the companies' plans. The news frustrated Dow officials who had hoped to have secured regulato
Competitors
| Price | Change | |
|---|---|---|
| BASF SE (BASFn.DE) | €75.35 | +1.41 |
| The Dow Chemical Company (DOW.N) | $35.75 | +0.14 |
| E I Du Pont De Nemours And Co (DD.N) | $55.98 | +0.05 |
| E I Du Pont De Nemours And Co (DD_pa.N) | $91.03 | -0.37 |
| E I Du Pont De Nemours And Co (DD_pb.N) | $105.00 | 0.00 |
| Bayer AG (BAYGn.DE) | €84.65 | +0.53 |
| Bayer AG (BAYE.F) | -- | -- |
| Syngenta AG (SYNN.VX) | CHF386.60 | -10.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (MON). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

